Model
Edge
Relmada Therapeutics, Inc.
RLMD
Filing Type
S-3ASR
Filing Date
4/6/2022
Updated
4/7/22, 11:14 AM
Filing
S-3ASR
Earnings Release
Exhibits
S-3ASR
S-3ASR
EX-1.2
OPEN MARKET SALE AGREEMENTSM BETWEEN RELMADA THERAPEUTICS, INC. AND JEFFERIES LLC DATED APRIL 7, 2022
EX-5.1
OPINION OF SICHENZIA ROSS FERENCE LLP
EX-5.2
OPINION OF SICHENZIA ROSS FERENCE LLP
EX-23.1
CONSENT OF MARCUM LLP
EX-FILING FEES
FEE TABLE
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic